Improving infant patient outcomes by providing clinicians with powerful insight
The new BeginNGS™ program, based at the Rady Children’s Institute for Genomic Medicine (RCIGM), is a novel health care delivery system designed to screen newborns for genetic diseases and connect their doctors with effective treatment options. It will improve infant patient outcomes by providing clinicians with powerful insight on how these diseases form, and how to treat them, creating life-saving opportunities for patients and their families at very early stages.
Mastermind: The premier resource of BeginNGS
As part of our mission to curate the entire human genome, Genomenon will combine AI-powered organization and expert manual review to fully curate all the genes in the BeginNGS screening panel – genes tied to over 400 diseases – and provide RCIGM with a comprehensive, actionable dataset on the variants that are found to cause disease.
Genomenon’s essential role in curating actionable genomic information and making it easily accessible to these professionals is helping transform that goal into a reality.
By screening for over 400 treatable conditions and providing treatment guidelines to doctors and other clinicians before symptoms start, BeginNGS is creating life-saving opportunities for patients and their families at very early stages. Genomenon is honored to play a part in this important mission.
Latest Blog Posts
Read about Genomenon’s mission to curate the entire human genome, how we’re making that happen, and more about our partnership with BeginNGS
READ MORE ABOUT THIS PARTNERSHIP
The World’s Most Comprehensive Source of Genomic Evidence
Meet the engine powering BeginNGS. Accelerate variant interpretation with immediate insight into the full text of millions of scientific articles. Prioritize your search results by clinical relevance and find what you are looking for 5-10 times faster
CREATE YOUR FREE ACCOUNT